COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:

Search Results

One moment please while the data are loaded...
View results
  • Organ: Skin
  • Level of Evidence: Positive, Clear Evidence, Some Evidence
Displays results that match exactly with the given criteria.
Exact Match Publication No. CASRN Test Article Name Species Sex Route Organ Level of Evidence Tumor Type/Incidence Finding Type
Yes TR-084 39156-41-7 2,4-Diaminoanisole sulfate Rats Male Dosed-Feed Skin Positive (SQUAMOUS CELL CARCINOMA OR BASAL CELL CARCINOMA OR SEBACEOUS ADENOCARCINOMA) Neoplastic Lesions
Yes TR-093 6109-97-3 3-Amino-9-ethylcarbazole HCl Rats Male Dosed-Feed Skin Positive (PAPILLOMA OR CARCINOMA) Neoplastic Lesions
Yes TR-054 121-14-2 2,4-Dinitrotoluene Rats Male Dosed-Feed Skin Positive (FIBROMA) Neoplastic Lesions
Yes TR-058 52-24-4 tris(Aziridinyl)-phosphine sulfide (thio-tepa) Mice Male Intraperitoneal Injection Skin Positive (SQUAMOUS CELL CARCINOMA) Neoplastic Lesions
Yes TR-058 52-24-4 tris(Aziridinyl)-phosphine sulfide (thio-tepa) Rats Female Intraperitoneal Injection Skin Positive (SQUAMOUS CELL CARCINOMA) Neoplastic Lesions
Yes TR-058 52-24-4 tris(Aziridinyl)-phosphine sulfide (thio-tepa) Rats Male Intraperitoneal Injection Skin Positive (SQUAMOUS CELL CARCINOMA) Neoplastic Lesions
Yes TR-127 99-59-2 5-Nitro-o-anisidine Rats Male Dosed-Feed Skin Positive (TRICHOEPITHELIOMA, SEBACEOUS ADENOMA, BASAL CELL CARCINOMA, SQUAMOUS CELL CARCINOMA, ADENOCARCINOMA) Neoplastic Lesions
Yes TR-128 91-93-0 3,3'-Dimethoxybenzidine-4,4'-diisocyanate Rats Male Dosed-Feed Skin Positive (BASAL CELL ADENOMA, SQUAMOUS CELL CARCINOMA) Neoplastic Lesions
Yes TR-146 139-94-6 Nithiazide Rats Female Dosed-Feed Skin Positive (FIBROADENOMA OR CYSTADENOMA) Neoplastic Lesions
Yes TR-289 71-43-2 Benzene Rats Male Gavage Skin Clear Evidence SQUAMOUS CELL PAPILLOMA 0/50 2/50 1/50 5/50; SQUAMOUS CELL CARCINOMA 0/50 5/50 3/50 8/50 Neoplastic Lesions
Yes TR-285 569-61-9 C.I. Basic red 9 monohydrochloride Rats Male Dosed-Feed Skin Clear Evidence TRICHOEPITHELIOMA 0/50 0/50 7/50; SEBACEOUS ADENOMA 0/50 0/50 5/50; SQUAMOUS CELL CARCINOMA 0/50 1/50 10/50 Neoplastic Lesions
Yes TR-372 20325-40-0 3,3'-Dimethoxybenzidine dihydrochloride Rats Male Dosed-Water Skin Clear Evidence BASAL CELL OR SEBACEOUS GLAND NEOPLASMS 2/60 33/45 56/75 41/60; SQUAMOUS CELL NEOPLASMS 0/60 13/45 28/75 22/60 Neoplastic Lesions
Yes TR-374 556-52-5 Glycidol Mice Female Gavage Skin Clear Evidence SQUAMOUS CELL PAPILLOMA 0/50 0/50 1/50 OR SQUAMOUS CELL CARCINOMA 0/50 0/50 1/50 COMBINED 0/50 0/50 2/50 Neoplastic Lesions
Yes TR-374 556-52-5 Glycidol Mice Male Gavage Skin Clear Evidence SQUAMOUS CELL PAPILLOMA 0/50 0/50 4/50 Neoplastic Lesions
Yes TR-374 556-52-5 Glycidol Rats Male Gavage Skin Clear Evidence SEBACEOUS GLAND ADENOMA 0/50 0/50 1/50, BASAL CELL CARCINOMA 0/50 4/50 2/50, OR SEBACEOUS GLAND ADENOCARCINOMA 0/50 0/50 1/50 COMBINED 0/50 5/50 4/50 Neoplastic Lesions
Yes TR-362 106-87-6 4-Vinyl-1-cyclohexene diepoxide Mice Female Topical Application Skin Clear Evidence SQUAMOUS CELL CARCINOMA 0/50 6/50 37/50 43/50 Neoplastic Lesions
Yes TR-362 106-87-6 4-Vinyl-1-cyclohexene diepoxide Mice Male Topical Application Skin Clear Evidence SQUAMOUS CELL CARCINOMA 0/50 14/50 40/50 43/50 Neoplastic Lesions
Yes TR-362 106-87-6 4-Vinyl-1-cyclohexene diepoxide Rats Female Topical Application Skin Clear Evidence BASAL CELL CARCINOMA 2/50 5/50 5/50; SQUAMOUS CELL CARCINOMA 0/50 16/50 34/50 Neoplastic Lesions
Yes TR-362 106-87-6 4-Vinyl-1-cyclohexene diepoxide Rats Male Topical Application Skin Clear Evidence BASAL CELL CARCINOMA 2/50 4/50 8/50; SQUAMOUS CELL CARCINOMA 0/50 33/50 36/50 Neoplastic Lesions
Yes TR-372 20325-40-0 3,3'-Dimethoxybenzidine dihydrochloride Rats Female Dosed-Water Skin Clear Evidence SQUAMOUS CELL PAPILLOMA 0/60 0/45 3/75 0/60; BASAL CELL NEOPLASMS 0/60 4/45 3/75 2/60 Neoplastic Lesions
Yes TR-390 612-82-8 3,3'-Dimethylbenzidine dihydrochloride Rats Female Dosed-Water Skin Clear Evidence BASAL CELL ADENOMA 0/60 3/45 5/75 5/60 OR BASAL CELL CARCINOMA 0/60 0/45 5/75 4/60 COMBINED 0/60 3/45 10/75 9/60; SQUAMOUS CELL PAPILLOMA 0/60 1/45 6/75 5/60 OR SQUAMOUS CELL CARCINOMA 0/60 2/45 4/75 7/60 COMBINED 0/60 3/45 9/75 12/60 Neoplastic Lesions
Yes TR-390 612-82-8 3,3'-Dimethylbenzidine dihydrochloride Rats Male Dosed-Water Skin Clear Evidence BASAL CELL ADENOMA 0/60 10/45 52/75 29/60 OR BASAL CELL CARCINOMA 0/60 1/45 4/75 2/60 COMBINED 0/60 11/45 54/75 30/60; SEBACEOUS GLAND ADENOMA 0/60 0/45 7/75 5/60; KERATOACANTHOMA 1/60 1/45 8/75 5/60; SQUAMOUS CELL PAPILLOMA 0/60 0/45 8/75 15/60 OR SQUAMOUS CELL CARCINOMA 0/60 2/45 10/75 13/60 COMBINED 0/60 2/45 17/75 27/60 Neoplastic Lesions
Yes TR-397 2429-74-5 C.I. Direct blue 15 Rats Female Dosed-Water Skin Clear Evidence SQUAMOUS CELL PAPILLOMA 0/50 2/35 5/65 5/50, SQUAMOUS CELL CARCINOMA 0/50 0/35 1/65 0/50, COMBINED 0/50 2/35 6/65 5/50 Neoplastic Lesions
Yes TR-397 2429-74-5 C.I. Direct blue 15 Rats Male Dosed-Water Skin Clear Evidence BASAL CELL ADENOMA 2/50 8/35 23/65 26/50, BASAL CELL CARCINOMA 0/50 2/35 4/65 10/50, COMBINED 2/50 9/35 27/65 28/50; SEBACEOUS GLAND ADENOMA 0/50 1/35 7/65 3/50; SQUAMOUS CELL PAPILLOMA 2/50 3/35 5/65 8/50, SQUAMOUS CELL CARCINOMA 0/50 1/35 7/65 13/50, COMBINED 2/50 4/35 11/65 19/50 Neoplastic Lesions
Yes TR-400 96-13-9 2,3-Dibromo-1-propanol Mice Female Topical Application Skin Clear Evidence SQUAMOUS CELL PAPILLOMA 0/50 1/50 5/50 OR SQUAMOUS CELL CARCINOMA 0/50 0/50 1/50 COMBINED 0/50 1/50 6/50; SEBACEOUS GLAND ADENOMA 0/50 3/50 2/50 Neoplastic Lesions
Yes TR-400 96-13-9 2,3-Dibromo-1-propanol Mice Male Topical Application Skin Clear Evidence SQUAMOUS CELL PAPILLOMA 0/50 3/50 9/50 OR SQUAMOUS CELL CARCINOMA 0/50 0/50 2/50 COMBINED 0/50 3/50 11/50; SEBACEOUS GLAND ADENOMA 0/50 1/50 8/50 Neoplastic Lesions
Yes TR-400 96-13-9 2,3-Dibromo-1-propanol Rats Female Topical Application Skin Clear Evidence SQUAMOUS CELL PAPILLOMA 0/50 0/50 2/50 OR SQUAMOUS CELL CARCINOMA 0/50 0/50 1/50 COMBINED 0/50 0/50 3/50; BASAL CELL NEOPLASMS, SEBACEOUS GLAND ADENOMA OR KERATOACANTHOMA 0/50 3/50 18/50 Neoplastic Lesions
Yes TR-400 96-13-9 2,3-Dibromo-1-propanol Rats Male Topical Application Skin Clear Evidence SQUAMOUS CELL PAPILLOMA 1/50 3/50 0/50 OR SQUAMOUS CELL CARCINOMA 0/50 5/50 8/50 COMBINED 1/50 8/50 8/50; BASAL CELL NEOPLASMS, SEBACEOUS GLAND ADENOMA, OR KERATOACANTHOMA 0/50 20/50 31/50 Neoplastic Lesions
Yes TR-405 6459-94-5 C.I. Acid red 114 Rats Female Dosed-Water Skin Clear Evidence BASAL CELL ADENOMA 0/50 3/35 5/65 3/50, BASAL CELL CARCINOMA 0/50 1/35 2/65 2/50, COMBINED 0/50 4/35 7/65 5/50 Neoplastic Lesions
Yes TR-405 6459-94-5 C.I. Acid red 114 Rats Male Dosed-Water Skin Clear Evidence BASAL CELL ADENOMA 1/50 4/35 26/65 30/50, BASAL CELL CARCINOMA 0/50 1/35 5/65 6/50, COMBINED 1/50 5/35 28/65 32/50; KERATOACANTHOMA 1/50 1/35 4/65 7/50; SEBACEOUS GLAND ADENOMA 0/50 1/35 5/65 5/50, SEBACEOUS GLAND CARCINOMA 1/50 0/35 0/65 1/50, COMBINED 1/50 1/35 5/65 6/50; SQUAMOUS CELL PAPILLOMA 1/50 0/35 3/65 2/50, SQUAMOUS CELL CARCINOMA 0/50 2/35 8/65 7/50, COMBINED 1/50 2/35 11/65 9/50 Neoplastic Lesions
Yes TR-452 3296-90-0 2,2-bis(Bromomethyl)-1,3-propanediol Rats Male Dosed-Feed Skin Clear Evidence SQUAMOUS CELL PAPILLOMA 1/51 0/53 2/51 5/55 11/60 OR KERATOACANTHOMA 3/51 5/53 11/51 16/55 10/60 OR TRICHOEPITHELIOMA 0/51 0/53 0/51 1/55 1/60 OR BASAL CELL ADENOMA 0/51 1/53 0/51 3/55 6/60 OR BASAL CELL CARCINOMA 0/51 0/53 2/51 2/55 0/60 OR SQUAMOUS CELL CARCINOMA 0/51 0/53 0/51 0/55 1/60 COMBINED 4/51 6/53 14/51 24/55 21/60 Neoplastic Lesions
Yes TR-485 434-07-1 Oxymetholone Rats Female Gavage Skin Clear Evidence COMBINED 0/50 0/50 4/50 5/50 Neoplastic Lesions
Yes TR-491 93-15-2 Methyleugenol Rats Male Gavage Skin Clear Evidence FIBROMA 1/50 9/50 8/50 5/50 4/50 OR FIBROMA OR FIBROSARCOMA 1/50 12/50 8/50 8/50 4/50 Neoplastic Lesions
Yes TR-504 88-72-2 o-Nitrotoluene Rats Female Dosed-Feed Skin Clear Evidence (SUBCUTANEOUS) FIBROMA 3/60 3/60 18/60 20/60 FIBROMA OR FIBROSARCOMA 3/60 3/60 21/60 22/60 Neoplastic Lesions
Yes TR-504 88-72-2 o-Nitrotoluene Rats Male Dosed-Feed Skin Clear Evidence (SUBCUTANEOUS) LIPOMA 0/60 4/60 13/60 13/60 10/60 12/60 FIBROMA 5/60 46/60 52/60 59/60 45/60 52/60 FIBROSARCOMA 0/60 7/60 17/60 20/60 8/60 12/60 COMBINED 5/60 47/60 55/60 59/60 47/60 53/60 Neoplastic Lesions
Yes TR-510 51-79-6 Urethane Mice Female Dosed-Water Skin Clear Evidence HEMANGIOSARCOMA 0/48 0/48 0/46 2/48 Neoplastic Lesions
Yes TR-510 51-79-6 Urethane Mice Male Dosed-Water Skin Clear Evidence SQUAMOUS CELL PAPILLOMA OR SQUAMOUS CELL CARCINOMA (0/47, 1/48, 5/47, 8/48) Neoplastic Lesions
Yes TR-558 14047-09-7 3,3',4,4'-Tetrachloroazobenzene Mice Female Gavage Skin Clear Evidence Fibrosarcoma 1/50 6/50 5/50 8/50 fibrosarcoma or malignant schwannoma 2/50 8/50 7/50 12/50 Neoplastic Lesions
Yes TR-564 106-94-5 1-Bromopropane Rats Male Inhalation Skin Some Evidence Keratoacanthoma 0/50 3/50 6/50 6/50 keratoacanthoma or squamous cell carcinoma 1/50 4/50 6/50 8/50 keratoacanthoma, basal cell adenoma or carcinoma or squamous cell carcinoma 1/50 7/50 9/50 10/50 Neoplastic Lesions
Yes TR-569 30516-87-1 3'-Azido-3'-deoxythymidine (AIDS) Mice Male Gavage Skin Some Evidence (subcutaneous tissue): fibroma, fibrous, histiocytoma, or fibrosarcoma 2/65 2/47 7/48 12/48 -- AZT/3TC/NVP Neoplastic Lesions
Yes TR-569 134678-17-4 Lamivudine (3TC) Mice Male Gavage Skin Some Evidence (subcutaneous tissue): fibroma, fibrous, histiocytoma, or fibrosarcoma 2/65 2/47 7/48 12/48 -- AZT/3TC/NVP Neoplastic Lesions
Yes TR-569 129618-40-2 Nevirapine (NVP)  Mice Male Gavage Skin Some Evidence (subcutaneous tissue): fibroma, fibrous, histiocytoma, or fibrosarcoma 2/65 2/47 7/48 12/48 -- AZT/3TC/NVP Neoplastic Lesions
Yes TR-574 87-66-1 Pyrogallol Mice Female Topical Application Skin Some Evidence (site of application): squamous cell carcinoma 0/50, 0/50, 0/50, 4/50 Neoplastic Lesions
Yes TR-588 5694-00-8 Glycidamide Mice Male Dosed-Water Skin Clear Evidence squamous cell papilloma 0/47 1/48 2/47 1/47 8/46 squamous cell carcinoma 0/47 0/48 0/47 0/47 2/46 squamous cell papilloma or carcinoma 0/47 1/48 2/47 1/47 9/46 Neoplastic Lesions
Yes TR-588 5694-00-8 Glycidamide Mice Female Dosed-Water Skin Clear Evidence fibrosarcoma 0/45 1/48 2/47 2/47 9/45 sarcoma 0/45 0/48 1/47 3/47 3/45 fibrosarcoma or sarcoma 0/45 1/48 3/47 5/47 12/45 Neoplastic Lesions
Yes TR-590 1309-64-4 Antimony Trioxide Mice Male Inhalation Skin Clear Evidence fibrous histiocytoma (0/50, 1/50, 1/50, 4/50); fibrous histiocytoma or fibrosarcoma (0/50, 1/50, 3/50, 4/50) Neoplastic Lesions
Yes TR-590 1309-64-4 Antimony Trioxide Mice Female Inhalation Skin Clear Evidence squamous cell carcinoma (0/50, 0/50, 0/50, 2/50) May Have Been Related
Yes TR-575 79-06-1 Acrylamide Mice Female Dosed-Water Skin Clear Evidence fibrosarcoma, fibrous histocytoma, myxosarcoma, neurofibrosarcoma, or sarcoma 0/48 0/46 3/48 10/45 6/43 squamous cell carcinoma 0/48 0/46 0/48 0/45 2/43 Neoplastic Lesions
Yes TR-575 79-06-1 Acrylamide Rats Female Dosed-Water Skin Clear Evidence subcutaneous tissue fibroma, fibrosarcoma or sarcoma 1/48 0/48 0/48 1/48 5/48 Neoplastic Lesions